Illumina Value Stock - Dividend - Research Selection
Market price: 243,22 USD
Illumina Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||545.000.000|
|Free cash flow||337.000.000|
|Liabilities & Shareholders equity||15.217.000.000|
|Diluted shares outstanding||153.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||37.212.659.712,00 USD|
|Indices||MSCI World Index,NASDAQ 100,NASDAQ Comp.,S&P 500|
|Sectors||Life Sciences Tools & Services|
|Raw Data Source||US GAAP in Millionen USD|
|Stock Split||2008-09-24,2.0000/1.0000; 2008-09-23,2.0000/1.0000|
Description of the company
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations. In February 2013, it completed the acquisition of Verinata Health, Inc. Effective July 23, 2013, Illumina Inc acquired Advanced Liquid Logic Inc.